Current Edition

clinical

Enrollment on Tazemetostat Clinical Trials Halted by the FDA

Enrollment has been halted by the FDA on clinical trials of tazemetostat in patients with various solid tumors and hematologic malignancies, according to Epizyme, the …

Continue Reading →